5.11 USD
-0.05 (-0.97%)
5.1 USD
-0.01 (-0.2%)
ChartMill assigns a Buy % Consensus number of 43% to ELYM. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.59. This target is -10.18% below the current price.
ELYM was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ELYM.
In the previous month the buy percentage consensus was at a similar level.
ELYM was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-03-08 | HC Wainwright & Co. | Reiterate | Neutral |
| 2023-02-10 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2022-10-28 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-16 | SVB Leerink | Maintains | Outperform |
| 2022-07-11 | SVB Leerink | Maintains | Outperform |
| 2022-04-26 | Guggenheim | Downgrade | Buy -> Neutral |
| 2022-04-26 | SVB Leerink | Maintains | Outperform |
| 2021-09-07 | Guggenheim | Initiate | Buy |
| 2021-09-07 | SVB Leerink | Initiate | Outperform |
| 2021-09-07 | Stifel | Initiate | Buy |
ELIEM THERAPEUTICS INC / ELYM FAQ
What is the average price target for ELIEM THERAPEUTICS INC (ELYM) stock?
6 analysts have analysed ELYM and the average price target is 4.59 USD. This implies a price decrease of -10.18% is expected in the next year compared to the current price of 5.11.
What is the consensus rating for ELIEM THERAPEUTICS INC (ELYM) stock?
The consensus rating for ELIEM THERAPEUTICS INC (ELYM) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.